General Catalyst

Faro Health Secures $20 Million to Scale the Digital Transformation of Clinical Studies

Retrieved on: 
Wednesday, February 8, 2023
Section 32, Software, Trial of the century, Polaris Partners, Whaling in the Faroe Islands, General Catalyst, Patient, SAN, Partnership, Clinical trial, Investment, Growth, Medical imaging

SAN DIEGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Faro Health Inc. , a cloud-computing company that is developing digital infrastructure for smart clinical trials, today announced $20 million in additional funding.

Key Points: 
  • SAN DIEGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Faro Health Inc. , a cloud-computing company that is developing digital infrastructure for smart clinical trials, today announced $20 million in additional funding.
  • The best-in-class Faro platform, powered by multifaceted data, provides teams that design and author clinical studies with real-time insights into the protocol design.
  • "The Faro platform helps teams understand and mitigate the risks involved in modern protocols with enormous savings in direct costs and time.
  • Our platform can also help amplify and accelerate biopharma's existing investments in Transcelerate's Common Protocol Template, Digital Data Flow, Content Reuse and other initiatives."

With Healthcare Jobs Set to Increase At Record Pace, Guild Enhances Its Commitment To Address Critical Workforce Challenges, Partners With 17 Healthcare Organizations

Retrieved on: 
Thursday, February 2, 2023
Sentara Healthcare, Aging in the American workforce, Medicine, Education, Herzing University, Louisiana State University, University, UCHealth, COVID-19, Health administration, RN, Health, CO, Children's Hospital Colorado, ProMedica, Sharp HealthCare, Ohio University, Patient, General Catalyst, Health equity, Health care, Allied health professions, MSN, Face, FAAN, Senior, Organization, AdventHealth, Workforce, Jefferson Health, Management, MD, Guild, Nursing

Collectively, this momentum is enabling Guild and its healthcare partners to address complex labor challenges and build accessible career pathways in the industry.

Key Points: 
  • Collectively, this momentum is enabling Guild and its healthcare partners to address complex labor challenges and build accessible career pathways in the industry.
  • Healthcare occupations are projected to increase 13 percent by 2031 , significantly faster than the workforce average.
  • “The challenges healthcare organizations and their employees are facing have existed for some time, but were exacerbated by the pandemic.
  • Guild is partnering with the most innovative organizations to implement real solutions,” said Hanna Patterson, Senior Vice President of Healthcare and Applied Learning at Guild.

Vannevar Labs Announces $75M Series B Funding Round

Retrieved on: 
Wednesday, January 18, 2023
SAN, Government, Policy, Growth, VC, Labs, Engineering, Silicon, Vannevar Bush Award, General Catalyst, Renewable energy, Felicis Ventures, Encryption

SAN FRANCISCO, Jan. 18, 2023 /PRNewswire/ -- Vannevar Labs, which provides state-of -the-art technology to overcome critical national security problems, today announced a $75M Series B. The investment was led by Felicis with new investors DFJ Growth and Aloft VC and existing General Catalyst, Point72, Costanoa Ventures, and Shield Capital. This brings Vannevar's total funding to over $90M raised. The company plans to use new capital to fund development of new products and win the company's first multi-year program from Decrypt.

Key Points: 
  • Vannevar Labs is a defense technology company bringing together government expertise with Silicon Valley engineering to solve some of the most important national security problems.
  • SAN FRANCISCO, Jan. 18, 2023 /PRNewswire/ -- Vannevar Labs, which provides state-of -the-art technology to overcome critical national security problems, today announced a $75M Series B.
  • "We exist to bring the best engineering and product talent to the most important national security problems," said Brett Granberg, CEO at Vannevar Labs.
  • "Vannevar Labs has already demonstrated a strong ability to get innovative tech into the hands of the defense community.

CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability

Retrieved on: 
Wednesday, January 4, 2023
Biomedicine, Hoffmann-La Roche, Khosla Ventures, Stanford University, D, Machine learning, Roivant Sciences, Agios Pharmaceuticals, Pfizer, Doctor of Philosophy, Drug discovery, Head, Research, General Catalyst, Publication, Biology, Master of Science, Medicine, The Tumor, University of Minnesota College of Food, Agricultural and Natural Resource Sciences, Intelligence, AMAG Pharmaceuticals, ARIAD Pharmaceuticals, 3D, Therapy, Drug development, Vertex, Deep learning, GSK, Toxicology, University, Family, Cancer Research UK, Cell, Senior, Weill Cornell Graduate School of Medical Sciences, Pharmacokinetics, Merck & Co., MBA, Data management, Moscow State University, Immersion, DPU, Medical device, Pharmaceutical industry, Management, Crystallography, Science, Health care, Economics, Pharmacology, AI, Nature

LONDON – 4 January 2023 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research Company discovering and developing transformational medicines, today announces the expansion of its leadership team with a series of key appointments to strengthen its drug discovery and development, as well as operational management capabilities.

Key Points: 
  • Enhanced leadership team brings strong AI and drug discovery expertise and experience, reinforcing CHARM Therapeutics’ existing R&D capabilities
    LONDON – 4 January 2023 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research Company discovering and developing transformational medicines, today announces the expansion of its leadership team with a series of key appointments to strengthen its drug discovery and development, as well as operational management capabilities.
  • These appointments will support CHARM as it builds out of its research and development function to advance discoveries driven by its proprietary 3D deep-learning engine towards development.
  • CHARM Therapeutics raised $50 million in a Series A financing round announced in 2022, led by F-Prime Capital and OrbiMed, with General Catalyst and Khosla Ventures.
  • Gary D. Glick Ph.D., Executive Chair of CHARM Therapeutics, commented: “The exceptional people joining CHARM bring the perfect combination of skills, from immersion in AI, oncology and translational research to long experience in organizational leadership.

Resilience Establishes Tom Gamble Memorial Scholarship Fund

Retrieved on: 
Wednesday, December 21, 2022
Founders Fund, SAN, Hygiene, CRV, Insurance, General Catalyst, Risk management, Zurich Insurance Group, Memory, Tom, SANS, Multimedia, Behavior, Economics, Lightspeed Venture Partners, SANS Institute, Financial services, Resilience, Risk

SAN FRANCISCO, Dec. 21, 2022 /PRNewswire/ -- Resilience , the next-gen cyber risk company, has established the Tom Gamble Memorial Scholarship Fund to pay tribute to the honor and memory of Tom Gamble who passed away in June.

Key Points: 
  • SAN FRANCISCO, Dec. 21, 2022 /PRNewswire/ -- Resilience , the next-gen cyber risk company, has established the Tom Gamble Memorial Scholarship Fund to pay tribute to the honor and memory of Tom Gamble who passed away in June.
  • Tom joined Resilience in the summer of 2020 and was the Global Chief Distribution Officer.
  • When he joined Resilience, Tom said: "Without exception, cyber risk is the top challenge for businesses today.
  • The Tom Gamble Memorial Scholarship Fund will help instill that spirit and drive to continuously seek out the best cybersecurity technology solution in tomorrow's industry leaders.

Collective Extends All-in-One Financial Solution for Solopreneurs to All 50 States

Retrieved on: 
Wednesday, December 14, 2022
Life, S, SAN, QED, Marketing, LegalZoom, Box, Freedom, General Catalyst, Movement, COVID-19, Dream, Workforce, Tax, Growth, Photography, Social media, Lyft, Video game, Collective

SAN FRANCISCO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Collective, the first all-in-one online back office platform designed for self-employed people, announced today that it is now available in all 50 states.

Key Points: 
  • SAN FRANCISCO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Collective, the first all-in-one online back office platform designed for self-employed people, announced today that it is now available in all 50 states.
  • Since the funding round, the company has rapidly added support for businesses-of-one in 40 new states, reaching national availability and almost tripling its revenue.
  • The growth of solopreneurship is accelerating exponentially, catalyzed by new opportunities and generational changes in work culture.
  • According to a Zippia report , 36% of the US workforce now participates in freelance work, a number that is projected to grow to over 50% by 2027.

As the Role of CHRO Evolves to “Moral Compass” of Companies, Guild Hires Patagonia Veteran Dean Carter as New Chief People Officer

Retrieved on: 
Monday, December 12, 2022
The Walt Disney Company, CHRO, CO, Head, Walt Disney, Sears Holdings, Entrepreneurship, Quicken Loans, Culture, HR, Equity, Ecosystem, General Catalyst, CFO, CHRO-TV, Knowledge, Education, F500, Target, Workforce, Curriculum, IP, Organization, Walmart, Guilder, Corporation, Beehive, Fossil Group, COVID-19, Policy, Trial balance, Management, American Express, Guild, Chipotle

Denver, CO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Guild , the leader in opportunity creation for America’s workforce, today announced Dean Carter, former Head of People and Culture at Patagonia, as Guild’s new Chief People Officer.

Key Points: 
  • Denver, CO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Guild , the leader in opportunity creation for America’s workforce, today announced Dean Carter, former Head of People and Culture at Patagonia, as Guild’s new Chief People Officer.
  • The CHRO was asked to transform during the COVID-19 pandemic and the ensuing recovery to fill new roles for the company as Chief Crisis Officer, Chief Medical Officer, Chief Diversity, Equity and Inclusion Officer, Chief Communications Officer, and so much more.
  • In decades prior when 83% of assets on the balance sheet were “tangible assets” the Chief Financial Officer (CFO) was seen as second in command to the Chief Executive Officer (CEO).
  • “Guild has a deep understanding of the expanding role of CHROs and their potential to make a change in their organizations and in the lives of their employees,” said Dean Carter, Guild’s Chief People Officer.

Armorblox Announces Significant Enhancements to its NLU-based Data Protection Platform

Retrieved on: 
Thursday, December 15, 2022
Online Privacy, Apps, Applications, Technology, Security, Software, Networks, Internet, Data Management, Artificial Intelligence, Ministry of Education (Malaysia), State Security Administration (Yugoslavia), API, PCI, Control, Gartner, BEC, PII, PHI, General Catalyst, Natural language, RBAC, Organization, Internet service provider, Risk management, Sales

Armorblox today announced the addition of Custom Role-Based Access Controls to its cloud-delivered email security platform to maintain data compliance and reduce data blindspots for individuals across the organization.

Key Points: 
  • Armorblox today announced the addition of Custom Role-Based Access Controls to its cloud-delivered email security platform to maintain data compliance and reduce data blindspots for individuals across the organization.
  • Armorblox offers enhanced security from insider threats with enhancements to Armorblox Advanced Data Loss Prevention and the addition of Custom Role-Based Access Controls (RBAC).
  • The expanded functionality of Armorblox Advanced Data Loss Prevention provides customers with precise protection across all confidential content types and sensitive data.
  • The Armorblox platform connects over APIs and analyzes thousands of signals to understand the context of communications and protect people and data from compromise.

Resilience Brings Its New Rules of Risk to NetDiligence 2023 Fort Lauderdale Cyber Risk Summit

Retrieved on: 
Thursday, December 15, 2022
BuzzFeed, New Yorker, Unitary state, Task force, Conference, Security, Private sector, Phillips, Lightspeed Venture Partners, Risk management, Bloomberg, Economics, Philips, Beazley, National Cyber Investigative Joint Task Force, Founders Fund, Behavior, CRV, General Catalyst, Fort Lauderdale, Florida, Multimedia, Government, Allianz, SAN, The New Yorker, Hygiene, Insurance, Private investigator, Resilience, Risk

SAN FRANCISCO, Dec. 15, 2022 /PRNewswire/ -- Resilience, the next-generation cyber risk company on a mission to help make the world cyber resilient, is proud to announce Chief Claims Officer Michael Phillips has been named a 2023 Conference Chair of NetDiligence's Fort Lauderdale Cyber Risk Summit.

Key Points: 
  • SAN FRANCISCO, Dec. 15, 2022 /PRNewswire/ --Resilience, the next-generation cyber risk company on a mission to help make the world cyber resilient, is proud to announce Chief Claims Officer Michael Phillips has been named a 2023 Conference Chair of NetDiligence's Fort Lauderdale Cyber Risk Summit.
  • Alongside supporting Resilience insureds, he also serves as Co-Chair of the Ransomware Task Force convened by the Institute for Security & Technology.
  • At NetDiligence, Phillips will discuss current trends in cyber claims and how the insurance industry can help clients build cyber resilience by rewriting the rules for how we can support and protect insureds.
  • Resilience helps middle-to-large market enterprises connect their cyber insurance coverage with advanced cybersecurity visibility and actionable cyber hygiene.

Vevo Therapeutics Launches with Oversubscribed $12M Seed Financing to Discover Better Drugs Using Higher Resolution In Vivo Data Generated at Scale

Retrieved on: 
Thursday, December 8, 2022
AIX, Gene expression, Therapy, Chemistry, Computational biology, Drug discovery, Patient, Research, Disease, AI, University of California, San Francisco, UCSF, Human, General Catalyst, Genomics, Multimedia, University, Atlas, Doctor of Philosophy, Invention, Associate, Pharmaceutical industry, Medicinal plants, Mosaic, Vevo

SAN FRANCISCO, Dec. 8, 2022 /PRNewswire/ -- Vevo Therapeutics, a biotechnology company using its Mosaic in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients, launched today with an oversubscribed and upsized $12M seed financing round. Wing Venture Capital and General Catalyst co-led the round with participation from Mubadala Capital, AIX Ventures, and Camford Capital.

Key Points: 
  • With the seed funding, Vevo will perform thousands of Mosaic experiments to create what is deemed impossible today: an in vivo atlas of how chemistry perturbs biology.
  • Vevo's AI models will be trained on this atlas to uncover novel targets and drugs undetectable by other technologies.
  • By starting and guiding drug discovery with high-resolution in vivo data, we are flipping the script on traditional discovery methods."
  • Vevo Therapeutics is a biotechnology company using itsin vivo drug discovery platform and next generation AI models to uncover better drugs for more patients.